When to Stop

• Serotonin syndrome when combined with strong serotonergic agents (MAOIs, SSRIs at high doses, tramadol, dextromethorphan, MDMA). The same warning applies as with tryptophan, but 5-HTP has higher per-mg serotonergic potency because of TPH bypass — so the risk threshold is lower. Avoid 5-HTP entirely if on an MAOI; use cautiously if at all on SSRI/SNRI.
• EMS-like illness from Peak X contamination — case reports exist. Risk is sourcing-dependent: stick to brands that test for Peak X (Doctor's Best, NOW Foods).
• Theoretical chronic-use cardiac valvulopathy via 5-HT2B receptor activation (the carcinoid/fenfluramine/pergolide mechanism). No human RCT has measured echo outcomes in chronic 5-HTP users. Mechanism-plausible but unconfirmed at supplement doses; the risk scales with dose, duration, and likely with peripheral 5-HT exposure (which is exactly where 5-HTP dumps most of its load). This is the strongest reason to avoid chronic high-dose 5-HTP.
• Allergic reactions — rare.
• First 2 weeks: GI tolerability assessment. If nausea persists or escalates, stop.
• First 4 weeks: mood drift assessment (the dopamine-depletion signature usually emerges in this window if it's going to).
• >3 months chronic daily use: the theoretical valvulopathy zone. No evidence-based interval, but serial echocardiograms are not unreasonable for users on chronic high-dose (>200 mg/day for >6 months).
• EMS vigilance: unusual muscle pain, eosinophilia, skin tightening, neuropathy — especially with low-cost unbranded 5-HTP. Stop immediately and seek medical evaluation.